We’re tracking in-house compensation. Take the Law360 Survey
Click here
USA v. PURDUE PHARMA L.P.
-
April 28, 2026
OxyContin maker Purdue Pharma LP has to pay a $3.5 billion fine and forfeit an additional $2 billion, more than five years after it pled guilty to criminal charges related to its role in the opioid crisis, a New Jersey federal judge said Tuesday.
-
April 24, 2026
A New York bankruptcy judge will consider whether the state's attorney general should be a creditor in a Roman Catholic diocese's Chapter 11, Purdue Pharma will receive its criminal sentence, and Saks Global Enterprises LLC will seek court approval of a plan disclosure statement.
-
April 21, 2026
A New Jersey federal judge delayed Oxycontin maker Purdue Pharma's criminal sentencing by a week, saying rescheduling would give an in-person attendance option to hundreds of observers who tuned in virtually Tuesday.
-
April 17, 2026
Purdue Pharma will undergo an omnibus hearing and get criminally sentenced, Office Properties Income Trust will seek plan confirmation and Spirit will vie for the all-clear to take a vote on its own plan.
-
April 13, 2026
Saks and mall owner Simon Property said they are closing in on an agreement resolving a dispute over leases, recycler Aleon Metals received plan approval and the American Bankruptcy Institute reported a first-quarter bump in bankruptcy filings.
-
April 10, 2026
More than five years after pleading guilty to conspiring to defraud the U.S. government, Purdue Pharma will be sentenced this month, according to a notice filed in the bankruptcy case of the OxyContin maker.